FAP and neoplasm: Our in vitro and in vivo results show that FAP UCAR T-cells enable the reprogramming of the cold, stroma-rich TNBC TME, making the tumor susceptible to subsequent Meso UCAR T infiltration and cytotoxicity and improving the overall antitumor activity of the treatment.